PHAR vs LXRX

Comparison between Pharming Group N.V. (PHAR, Company) and Lexicon Pharmaceuticals Inc (LXRX, Company).

Both PHAR and LXRX are from the Healthcare sector.

5-Year PerformancePHAR has outperformed LXRX, delivering a return of +3.3% compared to -9.6%

PHAR vs LXRX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	PHAR(COMPANY)	LXRX(COMPANY)
Market Cap	$940M	$937M
Max Drawdown	60.45%	99.91%
Sharpe Ratio	0.67	1.13
5Y Beta	0.66	1.11
Industry	Biotechnology	Biotechnology
P/E Ratio	75.03	-31.05
Forward P/E	24.27	N/A
5Y EPS CAGR	-19.96%	N/A
Debt to Equity	43.21%	24.49%
Free Cash Flow Yield	5.33%	-4.14%

Market Cap

Winner

PHAR

$940M

LXRX

$937M

Max Drawdown

Winner

PHAR

60.45%

LXRX

99.91%

Sharpe Ratio

PHAR

0.67

Winner

LXRX

1.13

5Y Beta

Winner

PHAR

0.66

LXRX

1.11

Industry

PHAR

Biotechnology

LXRX

Biotechnology

P/E Ratio

PHAR

75.03

Winner

LXRX

-31.05

Forward P/E

PHAR

24.27

LXRX

N/A

5Y EPS CAGR

PHAR

-19.96%

LXRX

N/A

Debt to Equity

PHAR

43.21%

Winner

LXRX

24.49%

Free Cash Flow Yield

Winner

PHAR

5.33%

LXRX

-4.14%

PHAR vs LXRX - Historical Returns

Returns include dividend reinvestment.

Period	PHAR	LXRX
1 month	+6.24%	+14.87%
3 months	-23.31%	+21.74%
6 months	-27.93%	+63.50%
1 year	+29.67%	+73.64%
5 years(CAGR)	+3.30%	-9.60%
10 years(CAGR)	N/A	-17.30%
Max(CAGR)	-4.02%	-14.35%

PHAR

+6.24%

Winner

LXRX

+14.87%

PHAR

-23.31%

Winner

LXRX

+21.74%

PHAR

-27.93%

Winner

LXRX

+63.50%

PHAR

+29.67%

Winner

LXRX

+73.64%

5Y(CAGR)

Winner

PHAR

+3.30%

LXRX

-9.60%

10Y(CAGR)

PHAR

N/A

LXRX

-17.30%

Max(CAGR)

Winner

PHAR

-4.02%

LXRX

-14.35%

PHAR vs LXRX - Annual Returns (2000 - 2026)

Returns include dividend reinvestment.

Year	PHAR	LXRX
2026	-22.46%	+96.49%
2025	+68.93%	+47.99%
2024	-12.49%	-53.55%
2023	-0.70%	-23.12%
2022	+24.49%	-50.90%
2021	-40.08%	+11.93%
2020	-9.01%	-16.38%
2019	N/A	-39.94%
2018	N/A	-34.39%
2017	N/A	-30.42%
2016	N/A	+5.17%
2015	N/A	+105.98%
2014	N/A	-49.17%
2013	N/A	-24.41%
2012	N/A	+76.80%
2011	N/A	-14.00%
2010	N/A	-16.76%
2009	N/A	+18.06%
2008	N/A	-54.10%
2007	N/A	-17.89%
2006	N/A	-5.25%
2005	N/A	-50.68%
2004	N/A	+28.18%
2003	N/A	+14.37%
2002	N/A	-57.69%
2001	N/A	-17.57%
2000	N/A	-11.31%

PHAR vs LXRX Drawdown Comparison

The maximum drawdown for PHAR was -60.45%, occurring on Jun 16, 2022. Recovery took 1225 trading sessions.

The maximum drawdown for LXRX was -99.91%, occurring on Mar 3, 2025. This drawdown has not yet recovered.

The current PHAR drawdown is -37.25%. The current LXRX drawdown is -99.32%.

Rank	PHAR	LXRX
#1	-60.45% Dec 23, 2020 - Nov 10, 2025	-99.91% Jul 21, 2000 - Mar 3, 2025
#2	-43.34% Jan 27, 2026 - May 7, 2026	-51.33% Apr 7, 2000 - Jun 20, 2000
#3	-10.93% Nov 26, 2025 - Dec 12, 2025	-15.33% Jul 10, 2000 - Jul 20, 2000
#4	-10.03% Nov 10, 2025 - Nov 13, 2025	-8.08% Jun 21, 2000 - Jun 23, 2000
#5	-9.70% Nov 13, 2025 - Nov 26, 2025	-5.17% Jun 28, 2000 - Jul 5, 2000
#6	-9.45% Dec 12, 2025 - Dec 24, 2025	N/A
#7	-7.08% Dec 24, 2025 - Jan 9, 2026	N/A
#8	-4.58% Jan 12, 2026 - Jan 22, 2026	N/A
#9	-1.15% Jan 22, 2026 - Jan 26, 2026	N/A